Mauro Maniscalco
Mauro Maniscalco is an expert in Pulmonology at Istituti Clinici Scientifici Maugeri (Italy). As of October 2026, ScienceLeadR ranks Mauro Maniscalco in the top 1% of experts worldwide for Lung Diseases, Obstructive. Mauro Maniscalco has authored 283 publications, the most recent in 2026, and is an investigator in 6 clinical trials, 3 of them ongoing. SLR score: 1,043 (community average: 125). How the SLR is computed.
LeadR Profile
Pulmonology
Subspecialties: Internal Medicine - Biochemistry - Pharmacy
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Short Biography
Scientific Director and Head of the Pulmonary Rehabilitation Division at the Istituti Clinici Scientifici Maugeri Research Institute in Telese, Italy. He was a research fellow at Papworth and Addenbrooke’s Hospitals in Cambridge, UK. He completed his PhD in the Department of Pharmacology at the Karolinska Institute in Stockholm, where he conducted research on exhaled nitric oxide in both the upper and lower airways. He is currently conducting research on airway inflammation and the outcomes of pulmonary rehabilitation.
Organizations
Career arc: 1997 - 2026
Number : 283
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Beyond Symptom Control: Remission as a Depth-Stratified Treatment Goal in Severe Asthma. PMID 42882147 — exercise, rehabilitation, airway remodeling, therapeutics, asthma, biological therapy | J Clin Med | 2026 | 0 |
| Appropriateness/inappropriateness of access to an in-hospital rehabilitation program for patients with respiratory disease. PMID 42845064 — hospitals, rehabilitation, respiratory tract diseases, rehabilitation, pulmonary disease, chronic obstructive, asthma, lung diseases, dyspnea, walk test | Monaldi Arch Chest Dis | 2026 | 0 |
| Intrinsic capacity is associated with cardiovascular rehabilitation outcome in older adults: a multidimensional comparison with frailty. PMID 42800461 — heart, aging, cardiac rehabilitation, rehabilitation, frailty | J Nutr Health Aging | 2026 | 0 |
| Looking beyond a single blood eosinophil count in COPD. PMID 42671054 — blood, eosinophils, biomarkers, pulmonary disease, chronic obstructive | Biomark Med | 2026 | 0 |
| Editorial: What's on the Horizon for asthma treatment? PMID 42666402 — airway remodeling, therapeutics, asthma | Front Pharmacol | 2026 | 0 |
Clinical Studies 6
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
3 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A study to investigate the effect of AZD6793 in participants with moderate to very severe chronic obstructive pulmonary disease 2025-520473-40-00 — safety, tablets, pulmonary disease, chronic obstructive, lung diseases, lung diseases, obstructive | Phase 2 | Recruiting | 2025 |
| Rehabilitation Training With Music support Exercise Tolerance in COPD and CRF Patients NCT05720780 — exercise, exercise tolerance, chronic disease, workload, rehabilitation, recycling, pulmonary disease, chronic obstructive, fatigue, therapeutics, lung diseases, dyspnea, physical exertion, movement, music therapy | N/A | Recruiting | 2023 |
| MANI Real life Perspective Observatory NCT04796844 — cohort studies, asthma | N/A | Recruiting | 2021 |
LeadR Networks
Main global connection map